The 2-DG drug, DRDO scientists say, will reduce 'oxygen Dependency' in COVID19 patients.
India came up with a new COVID19 drug, 2-deoxy-D-glucose (2-DG), approved on Saturday by the Drugs Controller General of India(DCGI). The approval is a massive relief for the country battling against COVID19.
"We tested this on hospital patients who were on oxygen support and over 200 patients have been given this drug, apart from the standard care and this has resulted in more benefits to the patients. The drug has taken more patients out of the oxygen dependency," Sudhir Chandana, DRDO scientist, said.
Dr. Chandana is hopeful that the drug will help the present crisis in the country. As tested, he is optimistic about a fast recovery in patients in the country and can be used with other standard care drugs.
Source: Republic World
At least ten people were missing after a boat capsized Wednesday in the Ghaghara River near the village of Mirzapur in the Lakhimpur Kheri district of...
Due to the repair work, Carried by the National Highway Authority of India, the vehicles are further permitted to ply from Tigri roundabout to Noida a...